<DOC>
	<DOCNO>NCT00165360</DOCNO>
	<brief_summary>The purpose trial determine effect ( good bad ) temozolomide patient low-grade glioma . It also determine whether temozolomide effective prevent delay future tumor growth .</brief_summary>
	<brief_title>Prolonged Daily Temozolomide Low-Grade Glioma</brief_title>
	<detailed_description>- Treatment temozolomide base upon 11-week cycle ( 7 week drug 4 week ) . Patients receive temozolomide daily 49 day , 28 day without take temozolomide . - Every two four week physical neurological examination blood work perform . A magnetic resonance imaging ( MRI ) scan patient 's brain do approximately every three month ( cycle treatment ) . - Treatment may continue maximum year half base 6 eleven-week cycle . The actual duration therapy depend upon response treatment development side effect toxicity .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Astrocytoma</mesh_term>
	<mesh_term>Oligodendroglioma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Histological confirmation lowgrade glioma ( astrocytoma , oligodendroglioma , mixed oligoastrocytoma ) Measurable disease MRI Patients undergone recent resection newly diagnose recurrent progressive tumor eligible recovered effect surgery . Patients recurrent disease one prior chemotherapy regimen Older 18 year age . Karnofsky performance status ( KPS ) performance score &gt; 70 % Adequate hematologic , renal liver function , Life expectancy great 12 week . Negative pregnancy test . Prior treatment temozolomide Patients neurologically stable Acute infection treat intravenous antibiotic Nonmalignant systemic disease Frequent vomiting , inability swallow medical condition could interfere oral medication . Previous concurrent malignancy sit , exception surgically cure carcinoma insitu cervix , basal squamous cell carcinoma skin . HIV positive AIDSrelated illness Pregnant nursing woman Patients allergy decarbazine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>low-grade glioma</keyword>
	<keyword>astrocytoma</keyword>
	<keyword>oligodendroglioma</keyword>
	<keyword>oligoastrocytoma</keyword>
	<keyword>temozolomide</keyword>
	<keyword>mixed oligoastrocytoma</keyword>
</DOC>